P60-AA03510/AA/NIAAA NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2008	2
2009	1
2010	8
2011	14
2012	13
2013	14
2014	15
2015	11
2016	8
2020	1
2021	1
2025	0

1

Contingency management treatments: controversies and challenges.

Petry NM. Petry NM. Addiction. 2010 Sep;105(9):1507-9. doi: 10.1111/j.1360-0443.2009.02879.x. Addiction. 2010. PMID: 20707772 Free PMC article.

2

The need for research addressing alcohol use disorder and diabetes.

Walter KN, Wagner JA, Cengiz E, Tamborlane WV, Petry NM. Walter KN, et al. Addiction. 2016 May;111(5):763-5. doi: 10.1111/add.13187. Epub 2015 Nov 21. Addiction. 2016. PMID: 26589363 No abstract available.

3

National gambling experiences in the United States: will history repeat itself?

Petry NM, Blanco C. Petry NM, et al. Addiction. 2013 Jun;108(6):1032-7. doi: 10.1111/j.1360-0443.2012.03894.x. Epub 2012 Oct 15. Addiction. 2013. PMID: 23067256 Free PMC article. Review.

4

Methadone deaths: risk factors in pain and addicted populations.

Modesto-Lowe V, Brooks D, Petry N. Modesto-Lowe V, et al. J Gen Intern Med. 2010 Apr;25(4):305-9. doi: 10.1007/s11606-009-1225-0. Epub 2010 Jan 20. J Gen Intern Med. 2010. PMID: 20087676 Free PMC article. Review.

5

Pharmacogenetics of alcohol and alcohol dependence treatment.

Kranzler HR, Edenberg HJ. Kranzler HR, et al. Curr Pharm Des. 2010;16(19):2141-8. doi: 10.2174/138161210791516387. Curr Pharm Des. 2010. PMID: 20482509 Free PMC article. Review.

6

Incentivizing behaviour change to improve diabetes care.

Petry NM, Cengiz E, Wagner JA, Hood KK, Carria L, Tamborlane WV. Petry NM, et al. Diabetes Obes Metab. 2013 Dec;15(12):1071-6. doi: 10.1111/dom.12111. Epub 2013 May 1. Diabetes Obes Metab. 2013. PMID: 23574494 Free PMC article. Review.

7

Towards a comprehensive developmental model of pathological gambling.

Blanco C, Hanania J, Petry NM, Wall MM, Wang S, Jin CJ, Kendler KS. Blanco C, et al. Addiction. 2015 Aug;110(8):1340-51. doi: 10.1111/add.12946. Epub 2015 Jun 6. Addiction. 2015. PMID: 25879250 Free PMC article.

8

Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism.

Kranzler HR, Covault J, Feinn R, Armeli S, Tennen H, Arias AJ, Gelernter J, Pond T, Oncken C, Kampman KM. Kranzler HR, et al. Am J Psychiatry. 2014 Apr;171(4):445-52. doi: 10.1176/appi.ajp.2013.13081014. Am J Psychiatry. 2014. PMID: 24525690 Free PMC article. Clinical Trial.

9

Balancing risk and benefit in heavy drinkers treated with topiramate: implications for personalized care.

Feinn R, Curtis B, Kranzler HR. Feinn R, et al. J Clin Psychiatry. 2016 Mar;77(3):e278-82. doi: 10.4088/JCP.15m10053. J Clin Psychiatry. 2016. PMID: 26891181 Free PMC article. Clinical Trial.

10

World Health Organization risk drinking levels as a treatment outcome measure in topiramate trials.

Hartwell EE, Feinn R, Witkiewitz K, Pond T, Kranzler HR. Hartwell EE, et al. Alcohol Clin Exp Res. 2021 Aug;45(8):1664-1671. doi: 10.1111/acer.14652. Epub 2021 Jul 5. Alcohol Clin Exp Res. 2021. PMID: 34120366 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Results by year